UNITE glioblastoma

Understanding and targeting resistance in glioblastoma

We aim to develop concepts to predict and monitor treatment response and failure, and ultimately, to discover novel therapies for glioblastoma patients

More about UNITE
Link to: Research
Brain Tumor scaled

UNITE School of Neurooncology

Member Teaser Image

MEMBERS

UNITE Glioblastoma brings together physician-scientists and scientists from Heidelberg University Hospital, University Hospital Mannheim, the German Cancer Research Center and Mannheim University of Applied Sciences.

EVENTS

UNITE coordinates regular seminars and symposia with internal and external speakers presenting the latest research findings in glioblastoma research.

Event Teaser Image

Participating Institutions

Header Image 3UNITE

Aurélie Ernst Awarded DFG Heisenberg Professorship

We applaud Aurélie Ernst (A08) on being awarded a DFG Heisenberg Professorship. Her research focuses on chromothripsis, a major form of genomic instability that drives cancer development, with the aim…
Header Image 3UNITE

NEWSLETTER 07/2026

We are happy to share recent highlights, including a recap of our seminar series, experiences from our travel grant recipients and the latest updates from research. This edition also features a curated…
Header Image 3UNITE

Automated and personalized glioblastoma tumor organoid drug screening platform exposes sensitivity to proteasome and HDAC inhibitors

Research findings related to UNITE work packages B04/C05/C06N Personalized drug screening aims to improve the survival of glioblastoma (GBM) patients by identifying effective patient-individual…